Candida auris is an emerging multi-drug resistant yeast that causes systemic infections.
Here we show that C. auris undergoes replicative aging (RA) that results from asymmetric …

Candida auris is a newly emerging fungal pathogen of humans and has attracted
considerable attention from both the clinical and basic research communities. Clinical …

Candida auris is an emerging fungal pathogen and a serious global health threat as the
majority of clinical isolates display elevated resistance to currently available antifungal …

Antifungal drug resistance and tolerance pose a serious threat to global public health. In the
human fungal pathogen, Candida auris, resistance to triazole, polyene, and echinocandin …

Candida auris is globally recognized as an opportunistic fungal pathogen of high concern,
due to its extensive multidrug resistance (MDR). Still, molecular mechanisms of MDR are …

The recently emerged pathogenic yeast Candida auris is a major concern for human health,
because it is easily transmissible, difficult to eradicate from hospitals, and highly drug …

Candida auris is an emerging yeast pathogen with a remarkable ability to develop antifungal
resistance, in particular to fluconazole and other azoles. Azole resistance in C. auris was …

Candida auris is an emerging yeast pathogen of major concern because of its ability to
cause hospital outbreaks of invasive candidiasis and to develop resistance to antifungal …

Candida auris is a multidrug-resistant fungal pathogen that presents a serious threat to
global human health. Since the first reported case in 2009 in Japan, C. auris infections have …

Candida auris exhibits resistance to multiple antifungal drug classes and sterilization
agents, posing threats to the immunocompromised worldwide. Among the four major …